Dr. Jonathan D. Cooper, MD

Dr. Cooper practices at South Florida ENT Associates, Inc. in Miami Lakes, Florida.

Dr. Cooper's NPI, 1407856222, was assigned on July 22, 2005. Dr. Cooper graduated from New York Medical College in 1987. Dr. Cooper holds Florida license ME56192.

Dr. Cooper's primary practice is South Florida ENT Associates, Inc., at 15280 Nw 79th Ct, Miami Lakes, FL 33016 in Miami-Dade County. The practice phone is (305) 558-3724.

Dr. Cooper's primary practice is South Florida ENT Associates, Inc. in Miami Lakes, Florida. Dr. Cooper is also affiliated with Memorial Hospital West. The medical group on file is South Florida ENT Associates. Dmand AI also links Dr. Cooper to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Cooper practices, 3 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. Cooper's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. Cooper is board certified in otolaryngology by the American Board of Otolaryngology - Head and Neck Surgery. Dr. Cooper is licensed in Florida.

Dmand AI lists acute sinusitis, chronic nasal allergies, ear eustachian tube disorders, ear infection, endoscopic sinus surgery, hearing loss and impairment, larynx and vocal cord disease and swimmer's ear among the conditions Dr. Cooper treats.

CMS data shows 1,444 Medicare services from Dr. Cooper across 16 procedure codes in 2024, for 533 Medicare patients. Medicare paid $82,448 for them. Every service was in an office.

CMS counts 533 Medicare patients who saw Dr. Cooper in 2024. The largest group is 65 to 74, with 241 patients. 75% of them have high cholesterol, and 72% have high blood pressure. 4% are also on Medicaid. Their average risk score is 1.10, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Cooper's median patient age at 61, with 54% women.

In 2024, Dr. Cooper wrote 725 Medicare Part D claims for 328 patients. 98% of them were for generic drugs. CMS names the drug for 645 of them, across 7 drugs with 11 or more claims each, at $13,572 in total drug cost. In 2023, CMS named 520 claims across 8 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Cooper for performance year 2024, reported individually. Dr. Cooper accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 90 papers to Dr. Cooper, published from 2003 to 2019. 2012 was the busiest year, with 9. The most frequent topics are Neuronal Ceroid-Lipofuscinoses, Disease Models, Animal and Brain. Dr. Cooper has published most often in Neurobiol Dis. Dr. Cooper's most frequent co-authors are Andrew Wei Ping Wong, Sandra Lee Hofmann, MD, PhD and Roy R. Casiano, MD.

CMS Open Payments shows 19 general payments to Dr. Cooper from 11 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Cipla USA Inc. paid the most, $442.

Dmand AI lists 2 awards for Dr. Cooper, most recently CMS Stage 1 EHR in 2013.

Dr. Cooper graduated from New York Medical College in 1987. Dr. Cooper is a member of NHS.

Dr. Cooper is in network with 17 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 11. Check the plan with the practice before a visit.